Variable | Normouricemic control | Gout | Asymptomatic Hyperuricemia |
---|---|---|---|
N | 34 | 24 | 29 |
Gender, male, n (%) | 34 (100 %) | 24 (100 %) | 29 (100 %) |
Age, years | 58 (14) | 58 (13) | 58 (19) |
Ethnicity, n (%) | European 30 (88 %) Māori 1 (3 %) Pacific 0 (0 %) Asian 3 (9 %) | European 14 (58 %) Māori 1 (4 %) Pacific 5 (21 %) Asian 4 (17 %) | European 24 (83 %) Māori 0 (0 %) Pacific 3 (10 %) Asian 2 (7 %) |
BMI, kg/m2 | 25.0 (2.9) | 30.2 (4.0)† | 29.3 (5.9)† |
Diuretic use, n (%) | 4 (12 %) | 3 (12 %) | 7 (24 %) |
Hypertension, n (%) | 9 (26 %) | 17 (70 %)† | 16 (55 %)† |
Cardiovascular disease, n (%) | 1 (3 %) | 7 (29 %)† | 5 (17 %) |
Diabetes, n (%) | 2 (6 %) | 4 (17 %) | 1 (3 %) |
Loss of protective sensation, n (%) | Right 1 (3 %) Left 1 (3 %) | Right 4 (17 %) Left 6 (25 %) | Right 4 (14 %) Left 4 (14 %) |
Serum urate | 0.32 (0.06) mmol/L 5.3 (1.0) mg/dL | 0.35 (0.10) mmol/L 5.8 (1.7) mg/dL | 0.46 (0.05) mmol/L† 7.6 (0.8) mg/dL |